Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,000
Closed -$3.44M 1084
2022
Q3
$3.44M Buy
40,000
+6,500
+19% +$580K 0.12% 216
2022
Q2
$3.05M Sell
33,500
-21,800
-39% -$1.93M 0.11% 235
2022
Q1
$4.54M Sell
55,300
-43,000
-44% -$3.39M 0.16% 134
2021
Q4
$7.53M Buy
98,300
+68,900
+234% +$5.49M 0.26% 60
2021
Q3
$2.21M Sell
29,400
-49,500
-63% -$3.76M 0.07% 414
2021
Q2
$6.14M Buy
78,900
+36,561
+86% +$2.72M 0.2% 80
2021
Q1
$3.11M Buy
42,339
+4,506
+12% +$332K 0.11% 258
2020
Q4
$2.95M Buy
+37,833
New +$2.89M 0.13% 175

Other funds holding MRK

Point72 Hong Kong's MRK Position: Q4 2024 in Review

Point72 Hong Kong sold out of Merck (MRK) in Q4 2024, closing a stake of 14,765 shares — an estimated $1.68M sold.

Point72 Hong Kong first reported a position in MRK in Q3 2014 and held it in 22 quarters. The position peaked at $15.5M in Q2 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Point72 Hong Kong reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 14,765 Merck shares in Q4 2024, an estimated $1.68M.
  • Point72 Hong Kong first reported a position in Merck in Q3 2014 and held it in 22 quarters.
  • Point72 Hong Kong's Merck position peaked at $15.5M in Q2 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Point72 Hong Kong's 13F filing for Q4 2024, filed 14 Feb 2025.